Qiagen NV
(XTER:QIA)
€
39.125
0.3 (0.77%)
Market Cap: 8.67 Bil
Enterprise Value: 9.24 Bil
PE Ratio: 27.85
PB Ratio: 2.59
GF Score: 86/100 - Q1 2024 Qiagen NV Earnings Call TranscriptApr 30, 2024€39.08 (-0.17%)Earnings
- Qiagen NV at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Qiagen NV Earnings Call TranscriptFeb 07, 2024€40.56 (-2.28%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Qiagen NV at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Qiagen NV at Jefferies London Healthcare Conference TranscriptNov 15, 2023
- Qiagen NV at Stifel Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Qiagen NV Earnings Call TranscriptOct 31, 2023€36.21 (+5.31%)Earnings
- Qiagen NV at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- Qiagen NV at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Qiagen NV Earnings Call TranscriptAug 09, 2023€42.19 (+0.86%)Earnings
- Qiagen NV Annual Shareholders Meeting TranscriptJun 22, 2023
- Qiagen NV at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Qiagen NV at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Qiagen NV Earnings Call TranscriptMay 04, 2023€43.4 (+3.36%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Qiagen NV at Citi Healthcare & Medtech Conference TranscriptMar 01, 2023
- Q4 2022 Qiagen NV Earnings Call TranscriptFeb 08, 2023€48.06 (+0.97%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Qiagen NV at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Qiagen NV at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Qiagen NV Earnings Call TranscriptNov 08, 2022€45.61 (+5.28%)Earnings
- Qiagen NV at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2022
- Qiagen NV at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Qiagen NV at Goldman Sachs European Medtech and Healthcare Services Conference TranscriptSep 07, 2022
- Q2 2022 Qiagen NV Earnings Call TranscriptJul 28, 2022€49.9 (+3.35%)Earnings
- Qiagen NV Annual Shareholders Meeting TranscriptJun 23, 2022
- Qiagen NV at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Qiagen NV at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Qiagen NV at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Qiagen NV Earnings Call TranscriptApr 28, 2022€44.75 (+4.53%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Qiagen NV at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Qiagen NV at Citi Healthcare Conference (Virtual) TranscriptFeb 23, 2022
- Q4 2021 Qiagen NV Earnings Call TranscriptFeb 09, 2022€45.68 (+3.05%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Qiagen NV at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Qiagen NV at Jefferies London Healthcare Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 Qiagen NV Earnings Call TranscriptNov 04, 2021€49.74 (+1.30%)Earnings
- Qiagen NV at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Qiagen NV at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Qiagen NV at Goldman Sachs MedTech Conference (Virtual) TranscriptSep 08, 2021
- Preliminary Q2 2021 Qiagen NV Earnings Call TranscriptJul 13, 2021€40.93 (-4.27%)Earnings
- Qiagen NV at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Qiagen NV at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Qiagen NV at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Qiagen NV Earnings Call TranscriptMay 04, 2021€40.68 (-1.33%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Qiagen NV at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Qiagen NV at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference TranscriptFeb 24, 2021
- Q4 2020 Qiagen NV Earnings Call TranscriptFeb 10, 2021€46.59 (+1.35%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Qiagen NV Virtual Deep Dive Event TranscriptDec 08, 2020
- Q3 2020 Qiagen NV Earnings Call TranscriptOct 28, 2020€43.14 (-1.11%)Earnings
- Qiagen NV Annual Shareholders Meeting TranscriptJun 30, 2020
- Thermo Fisher Scientific Inc to Acquire Qiagen NV Call TranscriptMar 03, 2020
- Q4 2019 Qiagen NV Earnings Call TranscriptFeb 05, 2020€32.94 (+4.93%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Qiagen NV Earnings Call TranscriptOct 31, 2019€27.74 (+2.99%)Earnings
- Qiagen NV at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Qiagen NV Earnings Call TranscriptJul 31, 2019€35.55 (+0.79%)Earnings
- Qiagen NV Analyst and Investor Day 2019 TranscriptJun 20, 2019
- Qiagen NV Annual Shareholders Meeting TranscriptJun 17, 2019
- Qiagen NV at Jefferies Healthcare Conference TranscriptJun 04, 2019
- Q1 2019 Qiagen NV Earnings Call TranscriptMay 07, 2019€34.13 (-3.95%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference TranscriptMar 14, 2019
Qiagen NV at Goldman Sachs European Medtech and Healthcare Services Conference Transcript
Sep 07, 2022 / 07:00AM GMT
Release Date Price:
€47.33
(-0.46%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Well, thank you, everybody, for joining us today. My name is Matt Sykes. I'm the senior life sciences tools and diagnostics analyst out of the U.S. I have the pleasure of welcoming QIAGEN to our conference this morning. We have Roland Sackers, the Chief Financial Officer; and John Gilardi, the VP of Communications and IR. Roland, John, thanks for joining us today.
Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board
Thanks for having us.
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
So maybe if we just let you kind of set the stage a little bit, talk about the most recent quarter and your expectations for the rest of the year.
Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board
Yes. Happy to do so. And yes, most of you are familiar faces. So I'm going to keep it brief and looking on the number of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)